
Bringing business impact to the science of R&D as a @ZSAssociates principal. Alum of @BerkeleyHaas & @WestPoint_USMA. Tweets are my own.
San Francisco, CA
Joined June 2012
- Tweets189
- Following269
- Followers92
- Likes67
This biotech milestone is one to celebrate. Regulators in the U.K. approved the first drug created with CRISPR gene editing technology, Casgevy, for the treatment of sickle cell disease and beta thalassemia #CRISPR #biotechnology #innovation
statnews.com/2023/11/16/cris… via @statnews
2
42
In ZS’s first-ever HEOR report, Barry Farrimond and George Agathangelou discuss the most pressing challenges that HEOR should be taking on: equitable pricing, emerging markets, demographic changes and health system capacity. #HEOR #pharma
zs.com/insights/technology-i…
32
I talked to @IBD_AGatlin recently about what the future holds for the Alzheimer’s market and the innovation we’re seeing in this space. #Alzheimers #biotechnology
investors.com/news/technolog… via @IBDinvestors
1
36
ZS’s @MariaWhitman and Bill Coyle are joined by clinical psychologist Mandi White-Ajmani, PhD, for a thoughtful, candid podcast episode about the short- and long-term impact of GLP-1s on patient outcomes, including mental health. #GLP1 #obesity
zs.com/insights/obesity-a-pa…
1
45
Four major #biopharma companies have partnered with Meharry Medical College to launch the largest ever database housing genomes exclusively from people with African ancestry. #healthequity #genomics
science.org/content/article/…
18
Great conversation on a HIMSS podcast featuring my colleague, Arnab Roy and guests from Takeda to discuss the role digital endpoints and biomarkers can play in decreasing trial burden and advancing rare disease research. zs.com/insights/digital-biom…
15
This collaboration between Roche and Medial EarlySign is a good example of how pharma companies are using AI to address some of the biggest challenges in cancer research. #AI #oncology #pharma bloomberg.com/news/articles/… via @business
1
5
If you’re attending the CNS Summit this week, don’t miss my colleague, April Lewis, who will be discussing opportunities for sponsors to collect and use patient insights in the delivery of clinical trials. #CNSSummit23 #patientexperience #clinicaltrials
9
My colleague Todd Greenwood helps explain how patients receiving CAR T-cell therapy can be safely monitored from home thanks to remote monitoring. #celltherapy #oncology #digitalhealth
zs.com/insights/how-remote-m…
5
Pharma companies can gain billions of dollars of operating income in a matter of years by scaling seven common digital programs. #digitaltransformation #ZSdigital #clinicaldevelopment
zs.com/insights/pharma-digit…
10
ZS research tells us that antibody drug conjugates (ADCs) are going to have a dramatic impact on the standard of care in oncology. Companies with ADC platforms should consider partnerships or acquisitions now. #oncology #pharma #ADCs pharmaphorum.com/oncology/an…
15
I’m thrilled that ZS was recently recognized as a Leader by IDC MarketScape in its first ever assessment of real-world evidence (RWE) and real-world data (RWD) consulting services and vendors. #RWE #RWD #lifesciences
zs.com/insights/idc-marketsc…
5
Sign up for ZS Discovery’s on-demand webinar about data management challenges and best practices for using multiomics to develop safer and more effective drugs. Register here: bit.ly/3rkxxf7
#omics #lifesciences #datamanagement
zs.com/insights/optimize-you…
8
ZS believes that the obesity market offers a unique opportunity for pharma manufacturers to take a bold step and rethink the traditional pharma model. #GLP1 #weightmanagement #obesity
zs.com/insights/pharma-comme…
6
I co-authored a piece with my colleagues Scott Sanford, Mike Martin and Max Luccock that explored five ways to safeguard the asset handoff process in #lifesciences R&D.zs.com/insights/how-to-overc…
2
It was great to see everyone at #BioTechX this week where I talked about the 5 pillars of pharma R&D transformation to improve the ROI on R&D investment and deliver better innovations to more patient faster.
12
A new ZS white paper shares strategies for using collaborative intelligence to drive innovation in clinical development. #AI #machinelearning #pharmahttps
zs.com/insights/zs-white-pap…
6
The discovery of a genetic variant that increases Parkinson’s risk in people of African descent could help fill a gap in understanding of an under-represented population. And hopefully improve treatments. #healthequity #Parkinsons #biopharma
statnews.com/2023/08/25/park…
13
I suspect we’ll start to see more partnerships like this one between BMS and Viz.ai that helps cardiologists identify candidates for new treatments. #pharma #healthtech
statnews.com/2023/08/15/bms-… via @statnews
10
Writing in @statnews, Liz Beatty shares makes a powerful case for why clinical trials should be more accessible to individuals with physical and intellectual disabilities. #clinicaltrials #healthequity
statnews.com/2023/08/17/clin… via @statnews
10
